These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24722208)

  • 1. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
    Schneikert J; Ruppert JG; Behrens J; Wenzel EM
    PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.
    Schneikert J; Vijaya Chandra SH; Ruppert JG; Ray S; Wenzel EM; Behrens J
    PLoS One; 2013; 8(7):e68072. PubMed ID: 23840886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
    Kohler EM; Brauburger K; Behrens J; Schneikert J
    Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible modification of adenomatous polyposis coli (APC) with K63-linked polyubiquitin regulates the assembly and activity of the β-catenin destruction complex.
    Tran H; Polakis P
    J Biol Chem; 2012 Aug; 287(34):28552-63. PubMed ID: 22761442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.
    Albuquerque C; Breukel C; van der Luijt R; Fidalgo P; Lage P; Slors FJ; Leitão CN; Fodde R; Smits R
    Hum Mol Genet; 2002 Jun; 11(13):1549-60. PubMed ID: 12045208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
    Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
    FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
    Kohler EM; Chandra SH; Behrens J; Schneikert J
    Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The two SAMP repeats and their phosphorylation state in Drosophila Adenomatous polyposis coli-2 play mechanistically distinct roles in negatively regulating Wnt signaling.
    Kunttas-Tatli E; Von Kleeck RA; Greaves BD; Vinson D; Roberts DM; McCartney BM
    Mol Biol Cell; 2015 Dec; 26(24):4503-18. PubMed ID: 26446838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Adenomatous polyposis coli tumour suppressor is essential for Axin complex assembly and function and opposes Axin's interaction with Dishevelled.
    Mendoza-Topaz C; Mieszczanek J; Bienz M
    Open Biol; 2011 Nov; 1(3):110013. PubMed ID: 22645652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
    Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
    Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 15-Amino Acid Repeat Region of Adenomatous Polyposis Coli Is Intrinsically Disordered and Retains Conformational Flexibility upon Binding β-Catenin.
    Rudeen AJ; Douglas JT; Xing M; McDonald WH; Lamb AL; Neufeld KL
    Biochemistry; 2020 Oct; 59(41):4039-4050. PubMed ID: 32941008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.
    Kishida S; Yamamoto H; Ikeda S; Kishida M; Sakamoto I; Koyama S; Kikuchi A
    J Biol Chem; 1998 May; 273(18):10823-6. PubMed ID: 9556553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and beta-catenin.
    Kawahara K; Morishita T; Nakamura T; Hamada F; Toyoshima K; Akiyama T
    J Biol Chem; 2000 Mar; 275(12):8369-74. PubMed ID: 10722668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.
    Xing Y; Clements WK; Kimelman D; Xu W
    Genes Dev; 2003 Nov; 17(22):2753-64. PubMed ID: 14600025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.
    Croy HE; Fuller CN; Giannotti J; Robinson P; Foley AVA; Yamulla RJ; Cosgriff S; Greaves BD; von Kleeck RA; An HH; Powers CM; Tran JK; Tocker AM; Jacob KD; Davis BK; Roberts DM
    J Biol Chem; 2016 Jun; 291(24):12747-12760. PubMed ID: 27068743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of the Axin-adenomatous polyposis coli interaction.
    Spink KE; Polakis P; Weis WI
    EMBO J; 2000 May; 19(10):2270-9. PubMed ID: 10811618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells.
    Yang J; Zhang W; Evans PM; Chen X; He X; Liu C
    J Biol Chem; 2006 Jun; 281(26):17751-7. PubMed ID: 16798748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
    Hinoi T; Yamamoto H; Kishida M; Takada S; Kishida S; Kikuchi A
    J Biol Chem; 2000 Nov; 275(44):34399-406. PubMed ID: 10906131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of adenomatous polyposis coli and beta-catenin to axin-puncta.
    Faux MC; Coates JL; Catimel B; Cody S; Clayton AH; Layton MJ; Burgess AW
    Oncogene; 2008 Oct; 27(44):5808-20. PubMed ID: 18591934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
    Hart MJ; de los Santos R; Albert IN; Rubinfeld B; Polakis P
    Curr Biol; 1998 May; 8(10):573-81. PubMed ID: 9601641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.